Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion type Assertion NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_head.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion wasGeneratedBy ECO_0000203 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion wasDerivedFrom befree-2016 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion SIO_000772 24312257 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion evidence source_evidence_literature NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.